ReproCELL Inc.
Stem cells research and flow cytometry
Reprocell Inc. was founded in 2003. Today 16 members are employed in the head office and laboratory subsidiary located in Tokyo, Japan. The company cooperates with research institutes of the Universities of Kyoto, Tokyo and Chiba.
Chikafumi Yokoyama, CEO
Yasuyuki Asai, Ph.D., CTO
Hiromitsu Nakauchi, MD, PhD, Director
ShirokanedaiUsui Bldg. 7F
3-16-13,Shirokanedai,
Minato-ku,Tokyo
108-0071
Japan
Phone: +03-5488-7077
Fax: +03-5488-0021
The company focuses on stem cell technology, including embryonic stem cells and somatic stem cells, which are used as the basis for developing applications in medical practice, basic research and drug discovery.
ReproCell’s major business is centred on flow cytometry services, the clinical examination of leukaemia, stem cell research-related agents and antibodies, and regenerative medicine.
The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.
Related patents
- Tailor-made Multifunctional Stem Cells and Utilization Thereof
- Undifferentiated State Marker Promoter of Cell and its Utilization
- Expansion Agents for Stem Cells
- Method and Composition for Regulating Expansion of Stem Cells
- Markers for Stem Cells and Transplantation Compatibility
- Marker for Adult Hematopoietic Stem Cell
- Method for Increasing Production of Blood Platelet Derived from Stem Cell
- Adoptive Immunity Gene Cell Therapy Using Cell Modified by Using Retrovirus
- Method and Composition for Regulating Expansion of Stem Cells
- Protein Sustaining Undifferentiated Stem Cells as Such